These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18049287)
1. The use of biologics and other immunosuppressants in the treatment of common inflammatory diseases in neuro-ophthalmology. Miller KB; Foroozan R Int Ophthalmol Clin; 2007; 47(4):151-60, x. PubMed ID: 18049287 [No Abstract] [Full Text] [Related]
2. Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease. Shah SB; Hanauer SB Rev Gastroenterol Disord; 2008; 8(3):159-68. PubMed ID: 18957923 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of biologics for the treatment of noninfectious uveitis. Takeuchi M Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801 [TBL] [Abstract][Full Text] [Related]
4. Biologics in the treatment of uveitis. Imrie FR; Dick AD Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000 [TBL] [Abstract][Full Text] [Related]
5. Use of immunosuppressive agents in uveitis. Lustig MJ; Cunningham ET Curr Opin Ophthalmol; 2003 Dec; 14(6):399-412. PubMed ID: 14615647 [TBL] [Abstract][Full Text] [Related]
6. [Acute rhinoethmoiditis with periorbital cellulitis in a newborn]. Falup-Pecurariu O; Apătăchioae ID; Falup-Pecurariu C; Bălescu A; Tecău M Oftalmologia; 2008; 52(3):39-46. PubMed ID: 19149116 [TBL] [Abstract][Full Text] [Related]
7. Orbital inflammatory disease. Danesh-Meyer HV; Rosser PM Int Ophthalmol Clin; 2007; 47(4):79-92, ix. PubMed ID: 18049282 [No Abstract] [Full Text] [Related]
8. Treating uveitis in the developing world setting. Rathinam SR Int Ophthalmol Clin; 2010; 50(2):219-28. PubMed ID: 20375873 [No Abstract] [Full Text] [Related]
9. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Tzu J; Kerdel F Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087 [TBL] [Abstract][Full Text] [Related]
11. Seronegative spondyloarthropathies and the eye. Ali A; Samson CM Curr Opin Ophthalmol; 2007 Nov; 18(6):476-80. PubMed ID: 18162999 [TBL] [Abstract][Full Text] [Related]
12. Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA)--a rare cause of fulminant orbital cellulitis. Shome D; Jain V; Natarajan S; Agrawal S; Shah K Orbit; 2008; 27(3):179-81. PubMed ID: 18569824 [TBL] [Abstract][Full Text] [Related]
13. [New therapy option for problem patients. What is the value of "biologics" in psoriasis?]. Boehncke WH MMW Fortschr Med; 2004 Nov; 146(46):45. PubMed ID: 15600044 [No Abstract] [Full Text] [Related]
14. Practical concepts in the management of uveitis. Biswas J Indian J Ophthalmol; 1993 Oct; 41(3):133-41. PubMed ID: 8125548 [No Abstract] [Full Text] [Related]
15. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice. Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800 [TBL] [Abstract][Full Text] [Related]
16. New biologics for glomerular disease on the horizon. Karras A; Jayne D Nephron Clin Pract; 2014; 128(3-4):283-91. PubMed ID: 25402272 [TBL] [Abstract][Full Text] [Related]